Main > GASTROENTEROLOGY > Crohn's Disease > Treatment > Tumor Necrosis Factor Inhibitors > Co.: USA. A (MAb/Approved/Patent)

---

Co.: USA. A (MAb/Approved/Patent)'s subsections
ChemoTherapy
Company
Generic Name: AdalimuMAb
Partner Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 05.23.06
TradeMark
UpDate: 03.13.08. (Press Release)

Co.: USA. A (MAb/Approved/Patent)'s products
This section has no products